Subsequent Events (Details Textual) - Subsequent Events [Member]		1 Months Ended
Feb. 07, 2018	Jan. 30, 2018
Subsequent Events (Textual)
Purchase of assets and liabilities, description		McLaughlin resigned as President and CEO, and Justin Schreiber was appointed as the Company's President and CEO. Additionally, Mr. McLaughlin agreed to purchase the assets and liabilities of the Immudyne Inc.'s yeast beta glucan manufacturing business for $850,000.
Assets purchase agreement, description	Mr. McLaughlin entered into an amendment to the asset purchase agreement to amend the purchase price of the assets, whereby Mr. McLaughlin agreed, through Newco, to purchase the assets of the yeast beta glucan manufacturing business, for the following (i) two million (2,000,000) shares of the Company's common stock payable on February 12, 2018 the Closing Date (ii) One Hundred and Ninety Thousand Dollars ($190,000) payable on the Closing Date, and (c) Two Hundred Thousand Dollars ($200,000) payable within 120 days following the Closing Date.

With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463

Name:	us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration